BioNukleo Information

We strive to make nucleoside and nucleotide analog production easier, cheaper and more sustainable! BioNukleo develops new (chemo-) enzymatic synthesis routes for nucleic acid derivatives. Due to our strong competence in the expression of challenging proteins, we have set up enzyme libraries with wide substrate promiscuity. They allow for the production of a broad range of nucleoside and nucleotide analogs. Together with partners we develop processes up to the industrial scale. Imprint http://www.bionukleo.com/imprint-1

Website	http://www.bionukleo.com
Revenue	$6 million
Employees	4 (4 on RocketReach)
Founded	2014
Address	Ackerstrasse 76, Berlin, Berlin 13355, DE
Phone	+49 30 31472183
Technologies	JavaScript , HTML , Twitter +9 more (view full list)
Industry	Biotechnology Research, Business Services General, Nucleosides, Business Services, Nucleotides, Non-Natural Nucleosides, Image Analysis
Keywords	Chemical Synthesis, Dna Synthesis, Rna Synthesis, Oligonucleotide Synthesis, Biocatalysis, Synthetic Biology, Pharmaceutical Intermediates, Drug Development, Gene Synthesis, Custom Synthesis, Process Chemistry, Green Chemistry, Sustainable Chemistry, Biotechnology, Life Sciences
Competitors	Thermo Fisher Scientific, Merck Group, SAFC, QIAGEN, Agilent Technologies, Illumina, Promega Corporation, Bio-Rad Laboratories, GE HealthCare, Fisher Scientific +43 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies